Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making significant ...

Boston Scientific (BSX) closed the most recent trading day at $101.64, moving +1.33% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.53% for the day.

Boston Scientific Corp. closed 0.01% short of its 52-week high of $101.65, which the company reached on January 22nd.

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

Boston Scientific Corp (BSX) stock saw a decline, ending the day at $100.31 which represents a decrease of $-0.60 or -0.59% from the prior close of $100.91. The stock opened at $100.91 and touched a ...

Morgan Stanley analyst Patrick Wood maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of ...

In August, a single email triggered a chain of hand-wringing and strategizing inside one of America’s largest medical technology companies: A reporter asked Boston Scientific if the biotech ...

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

At the J.P. Morgan Healthcare Conference, Boston Scientific forecast that pulsed field ablation will be used in more than 60% of atrial fibrillation procedures globally by 2026.

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $98.66 which represents a slight increase of $0.49 or 0.50% from the prior close of $98.17. The stock opened at $97.93 and ...